| Regulation of cerebral cortex folding by controlling neuronal migration via FLRT adhesion molecules D Del Toro, T Ruff, E Cederfjäll, A Villalba, G Seyit-Bremer, V Borrell, ... Cell 169 (4), 621-635. e16, 2017 | 131 | 2017 |
| Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson’s disease T Björklund, T Carlsson, EA Cederfjäll, M Carta, D Kirik Brain 133 (2), 496-511, 2010 | 59 | 2010 |
| Gene therapy for Parkinson's disease: disease modification by GDNF family of ligands D Kirik, E Cederfjäll, G Halliday, Å Petersén Neurobiology of disease 97, 179-188, 2017 | 53 | 2017 |
| Design of a single AAV vector for coexpression of TH and GCH1 to establish continuous DOPA synthesis in a rat model of Parkinson's disease E Cederfjäll, G Sahin, D Kirik, T Björklund Molecular Therapy 20 (7), 1315-1326, 2012 | 45 | 2012 |
| Continuous DOPA synthesis from a single AAV: dosing and efficacy in models of Parkinson's disease E Cederfjäll, N Nilsson, G Sahin, Y Chu, E Nikitidou, T Björklund, ... Scientific reports 3 (1), 2157, 2013 | 35 | 2013 |
| Controlled striatal DOPA production from a gene delivery system in a rodent model of Parkinson's disease E Cederfjäll, L Broom, D Kirik Molecular Therapy 23 (5), 896-906, 2015 | 28 | 2015 |
| Gene therapy for dopamine replacement T Björklund, EA Cederfjäll, D Kirik Progress in brain research 184, 220-235, 2010 | 14 | 2010 |
| Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain E Cederfjäll, G Sahin, D Kirik Neurobiology of disease 48 (2), 222-227, 2012 | 12 | 2012 |
| Reduced baseline sensitivity to maraviroc inhibition among R5 HIV-1 isolates from individuals with severe immunodeficiency U Karlsson, J Repits, L Antonsson, E Cederfjäll, B Ljungberg, M Ålenius, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 71 (3), e79-e82, 2016 | 5 | 2016 |
| Gene expression system and regulation thereof D Kirik, E Cederfjäll US Patent App. 15/300,686, 2017 | | 2017 |
| Novel strategies for enzyme replacement with gene therapy in models of Parkinson’s disease E Cederfjäll Lund University Faculty of Medicine Doctoral Dissertation Series 2014 (47), 2014 | | 2014 |
Tomas BjörklundProfessor of Neuroscience, Wallenberg Neuroscience Center, Lund University, SwedenVerified email at med.lu.se
